REHOVOT, Israel, April 30, 2019 /PRNewswire/ -- Evogene Ltd. (NASDAQ: EVGN) (TASE: EVGN), a leading biotechnology company developing novel products for life science markets, announced today that it has filed its annual report on Form 20-F for the fiscal year ended December 31, 2018 with...
from PR Newswire: https://prn.to/2XSY7Yf
No comments:
Post a Comment